Select Page

Dr. Novack’s contributions to the Journal of Ocular Pharmacology and Therapeutics highlighted

In a recent article in the Journal of Ocular Pharmacology and Therapeutics (JOPT), the present editor, Uday Kompella PhD of the University of Colorado, joined with past editors Craig Crosson Ph.D., David E. Potter, Ph.D., and W. Dan Stamer, Ph.D. to mark the 40th anniversary of the journal. In the article, they note the Dr. Novack for over 10 years of service in keeping the JOPT audience up to date on the status of novel ocular therapeutics and government regulations that affect their development. In addition, Drs.
Stamer and Novack wrote about the importance of ‘‘Therapeutics’’ in the title and mission of JOPT, hearkening back to Dr. Chiou’s name change in 1995.

Stamer WD, Crosson CE, Potter DE, Kompella UB. The JOPT Story: 40 Years of Growth and Focus. J Ocul Pharmacol Ther 2024;40(3):155-6.

Recent Posts

Gary D. Novack, PhD, president of PharmaLogic Development

Dr. Novack speaking at ASCRS 2014

Dr. Novack talked in two symposia at the Glaucoma 360 event of the Glaucoma Research Foundation in San Francisco.

PharmaLogic sponsor a northern California bicycle riding team “Caballo Rojo

UCSC Chancellor George Blumenthal and Foundation President Ken Doctor thank Dr. Novack for his service to UCSC.

Dr. Novack on floor of California State Assembly with Assemblymember Beall (D-San Jose)

Dr. Novack addresses European Glaucoma Society on Generic Drugs

Dr. Novack with Dr. Wiley Chambers (FDA/CDER), Dr. Ellen Strahlman (CMO GSK), and Dr. Malvina Eydelman (FDA/CDRH) at the Glaucoma 360 event.

Dr. Novack speaking at International Symposium on Ocular Pharmacology and Therapeutics, Vienna, Austria

Dr. Elizabeth Moyer and Dr. Novack at ophthalmology workshop European Medicines Agency

Dr. Novack presents young investigator award at ASPET to Stephanie Piecewicz of MIT